Frances Lasowski Ph.D. is a Chemical Engineer with expertise in biomaterials and drug delivery and training in commercialization. As Executive Director of the C20/20 Innovation Hub, she has an extensive network of ophthalmic contacts.  A former Vanier scholar, Lasowski completed her PhD at McMaster University within the NSERC 20/20 Network and has been involved in the ophthalmic space for over 12 years. 

Lasowski has entrepreneurial experience with the commercialization of the micelles for ocular applications.  As a co-founder and CEO of 20|20 OptimEyes Technologies, she brings an entrepreneurial understanding to the team. Lasowski is an Adjunct Associate Professor in the Booth School of Engineering Practice and Technology and an Innovation Consultant and Coach with the Michael G. DeGroote Initiative for Innovation in Healthcare at McMaster University.

• 

  Chief Executive Officer (CEO) in 20/20 OptimEyes Technologies

  REVOLUTIONIZING MUCOSAL DRUG DELIVERY